Related Experiment Video
Updated: May 30, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
The P2Y(6) receptor stimulates bone resorption by osteoclasts
Isabel R Orriss1, Ning Wang, Geoffrey Burnstock
1Department of Cell and Developmental Biology, University College London, London WC1E 6BT, United Kingdom. i.orriss@ucl.ac.uk
Extracellular UDP, via P2Y(6) receptors, promotes osteoclast formation and activity, crucial for bone remodeling. P2Y(6) receptor deficiency in mice leads to increased bone mass, indicating its regulatory role in bone cell function.
Area of Science:
- Bone biology
- Cell signaling
- Extracellular nucleotide metabolism
Background:
- Extracellular nucleotides and P2 receptors are implicated in bone remodeling.
- The specific role of the P2Y(6) receptor in osteoclast and osteoblast function remains largely undefined.
Purpose of the Study:
- To investigate the function of the P2Y(6) receptor in bone remodeling.
- To determine the impact of extracellular UDP on osteoclast formation and activity.
- To assess the in vivo role of the P2Y(6) receptor in bone metabolism.
Main Methods:
- In vitro studies using osteoclast precursors and mature osteoclasts.
- Assessment of osteoclast formation and resorptive activity.
- In vivo studies using P2Y(6) receptor-deficient (P2Y(6)R(-/-)) mice.
- Dual energy x-ray absorptiometry (DXA) and microcomputed tomography (micro-CT) analyses.
- Histomorphometric analysis of bone structure.
Main Results:
- Extracellular UDP stimulates osteoclast formation and enhances resorptive activity via P2Y(6) receptors.
- Osteoclasts from P2Y(6)R(-/-) mice exhibited impaired function in vitro.
- P2Y(6)R(-/-) mice displayed increased bone mineral content, cortical bone volume, and cortical thickness.
- Reduced osteoclast surface coverage on endocortical and trabecular bone surfaces in P2Y(6)R(-/-) mice.
- Trabecular bone parameters were not significantly affected.
Conclusions:
- The P2Y(6) receptor, activated by extracellular UDP, plays a significant role in regulating osteoclast function.
- P2Y(6) receptor signaling is critical for normal bone remodeling processes in vivo.
- Targeting the P2Y(6) receptor may offer therapeutic potential for bone metabolic disorders.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Osteoclasts in Bone Remodeling
Bone Remodeling
Skeleton and Calcium Homeostasis
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
